U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H17N2O
Molecular Weight 277.3404
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 1

SHOW SMILES / InChI
Structure of ELLIPTINIUM

SMILES

CC1=C2C=C[N+](C)=CC2=C(C)C3=C1NC4=C3C=C(O)C=C4

InChI

InChIKey=YZQRAQOSAPWELU-UHFFFAOYSA-O
InChI=1S/C18H16N2O/c1-10-15-9-20(3)7-6-13(15)11(2)18-17(10)14-8-12(21)4-5-16(14)19-18/h4-9,21H,1-3H3/p+1

HIDE SMILES / InChI

Molecular Formula C18H16N2O
Molecular Weight 276.3324
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Elliptinium is an antineoplastic agent, which was used in the treatment of metastatic breast cancer in France under the name Celiptium. The drug is known to intercalate into DNA and inhibit topoisomerase II. Several studies have demonstrated that this molecule can be oxidized, yielding a reactive electrophilic form, which is able to bind covalently to a nucleophilic biological molecule.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
CELIPTIUM

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Virostatic in vivo effect of elliptinium on Friend's retrovirus (a model for HIV infection).
1990
Anti-cryptosporidial drug activity screened with an immunosuppressed rat model.
1991 Nov-Dec
Assessment of candidate anticryptosporidial agents in an immunosuppressed rat model.
1993 Mar
Inhibitors of human immunodeficiency virus integrase.
1993 Mar 15
Viral and immunologic follow up of 4 to 9 years of AIDS treatments by quadruple combinations of virostatics including integrase inhibitors applied in short sequences differing by drug rotation.
2002 Jan
Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1.
2005 Nov 28
Anticancer drugs from marine flora: an overview.
2010
Immunotargeting of collagenase on thrombus.
2010 Nov 16

Sample Use Guides

In a clinical study, elliptinium (acetate salt) was given at a dose of 80 mg/m2 daily for 3 consecutive days every 21 days.
Route of Administration: Intravenous
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:02:36 GMT 2023
Edited
by admin
on Fri Dec 15 16:02:36 GMT 2023
Record UNII
1F1959S062
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ELLIPTINIUM
WHO-DD  
Common Name English
NSC-264137 ION
Code English
ELLIPTINIUM ION
Common Name English
ELLIPTINIUM CATION
Common Name English
Elliptinium [WHO-DD]
Common Name English
9-HYDROXY-2-METHYLELLIPTICINIUM
Common Name English
9-HYDROXY-2,5,11-TRIMETHYL-6H-PYRIDO(4,3-B)CARBAZOLIUM
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C582
Created by admin on Fri Dec 15 16:02:36 GMT 2023 , Edited by admin on Fri Dec 15 16:02:36 GMT 2023
NCI_THESAURUS C1968
Created by admin on Fri Dec 15 16:02:36 GMT 2023 , Edited by admin on Fri Dec 15 16:02:36 GMT 2023
Code System Code Type Description
SMS_ID
100000087741
Created by admin on Fri Dec 15 16:02:36 GMT 2023 , Edited by admin on Fri Dec 15 16:02:36 GMT 2023
PRIMARY
DRUG CENTRAL
996
Created by admin on Fri Dec 15 16:02:36 GMT 2023 , Edited by admin on Fri Dec 15 16:02:36 GMT 2023
PRIMARY
NCI_THESAURUS
C90495
Created by admin on Fri Dec 15 16:02:36 GMT 2023 , Edited by admin on Fri Dec 15 16:02:36 GMT 2023
PRIMARY
MESH
C027767
Created by admin on Fri Dec 15 16:02:36 GMT 2023 , Edited by admin on Fri Dec 15 16:02:36 GMT 2023
PRIMARY
EVMPD
SUB01869MIG
Created by admin on Fri Dec 15 16:02:36 GMT 2023 , Edited by admin on Fri Dec 15 16:02:36 GMT 2023
PRIMARY
FDA UNII
1F1959S062
Created by admin on Fri Dec 15 16:02:36 GMT 2023 , Edited by admin on Fri Dec 15 16:02:36 GMT 2023
PRIMARY
PUBCHEM
42723
Created by admin on Fri Dec 15 16:02:36 GMT 2023 , Edited by admin on Fri Dec 15 16:02:36 GMT 2023
PRIMARY
CAS
58337-34-1
Created by admin on Fri Dec 15 16:02:36 GMT 2023 , Edited by admin on Fri Dec 15 16:02:36 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY